Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 6,500 shares at $172.86 ($1.1M) on 2021-02-01, disclosed to the SEC on 2021-02-02.
Open-market sale of $1.1M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.16 | 400 | $62K | 5.9% |
| 2 | $157.28 | 800 | $126K | 11.9% |
| 3 | $158.28 | 400 | $63K | 6.0% |
| 4 | $159.20 | 800 | $127K | 12.0% |
| 5 | $159.20 | 800 | $127K | 12.0% |
| 6 | $160.33 | 300 |
| $48K |
| 4.5% |
| 7 | $162.00 | 300 | $49K | 4.6% |
| 8 | $163.07 | 300 | $49K | 4.6% |
| 9 | $164.20 | 600 | $99K | 9.3% |
| 10 | $165.32 | 200 | $33K | 3.1% |
| 11 | $171.30 | 100 | $17K | 1.6% |
| 12 | $172.86 | 700 | $121K | 11.4% |
| 13 | $172.86 | 700 | $121K | 11.4% |
| 14 | $174.00 | 100 | $17K | 1.6% |
| Total | $163.09 avg | 6,500 | $1.1M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |